デフォルト表紙
市場調査レポート
商品コード
1085822

組織および臓器移植の市場規模・シェア・展望・機会 (2022年~2028年):製品タイプ・用途・エンドユーザー・地域別

Tissue and Organ Transplantation Market, by Product Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 220 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
組織および臓器移植の市場規模・シェア・展望・機会 (2022年~2028年):製品タイプ・用途・エンドユーザー・地域別
出版日: 2022年05月13日
発行: Coherent Market Insights
ページ情報: 英文 220 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の組織および臓器移植の市場は、移植手術の技術的進歩により、予測期間中に大きな成長を示すと予測されています。

当レポートでは、世界の組織および臓器移植の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、法規制環境、技術動向、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査目的・前提条件

第2章 市場概要

第3章 市場力学・法規制・動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 規制シナリオ
  • 影響分析
  • PEST分析
  • ポーターの分析
  • 技術革新の進歩
  • 市場動向
  • 移植ツーリズムの成長
  • 主な展開

第4章 世界の組織および臓器移植市場:COVID-19の影響

  • 供給サイド分析
  • 需要サイド分析
  • ヘルスケア産業への影響

第5章 世界の組織および臓器移植市場:製品タイプ別

  • 組織製品
  • 保存溶剤
  • 免疫抑制薬

第6章 世界の組織および臓器移植市場:用途別

  • 臓器移植
  • 組織移植

第7章 世界の組織および臓器移植市場:エンドユーザー別

  • 病院
  • 移植センター
  • その他

第8章 世界の組織および臓器移植市場:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • アフリカ
  • 中東

第9章 競合情勢

  • 企業プロファイル
    • CryoLife, Inc.
    • Folio Biosciences
    • Arthrex
    • Abbvie, Inc.
    • Zimmer Biomet
    • Medtronic PLC
    • Novartis AG
    • Stryker Corporation
    • BiolifeSolutions, Inc.
    • Teva Pharmaceuticals
    • Veloxis Pharmaceutical

第10章 セクション

目次
Product Code: CMI4342

Transplantation is a complex area of medicine because when organs or tissues are transplanted from one person to another, the recipient's immune system can reject and destroy the donor organ or tissue and medication would be needed to suppress this immune response.

Organ transplantation is the surgical operation carried out for replacement of damaged organ of an individual. Donated organs are obtained from living donor, deceased donor or from an animal. Whereas in some cases, an artificial organ is used for the transplantation procedure.

Market Dynamics

The global tissue and organ transplantation market is expected to witness significant growth during the forecast period, owing to the technological advancements in transplantation procedures. For instance, in May 2016, Immucor, Inc., a global leader in transfusion and transplantation diagnostics, launched kidney Solid Organ Response Test, kSORT. It is a molecular gene expression assay that measures a kidney recipient's immune response to predict organ rejection and graft injury.

Key features of the study:

  • This report provides in-depth analysis of the global tissue and organ transplantation market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global tissue and organ transplantation market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include CryoLife, Inc., Folio Biosciences, Arthrex, AbbVie, Inc., Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, Biolife Solutions, Inc. , Teva Pharmaceuticals, and Veloxis Pharmaceutical
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological up gradation, market expansion, and marketing tactics
  • The global tissue and organ transplantation market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the tissue and organ transplantation market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Tissue and Organ Transplantation Market, By Product Type:
  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs

Global Tissue and Organ Transplantation Market, By Application:

  • Organ Transplantation
  • Tissue Transplantation
  • Global Tissue and Organ Transplantation Market, By End User:
  • Hospital
  • Transplant Centers
  • Others
  • Global Tissue and Organ Transplantation Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
    • By Product Type:
  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs
    • By Application
  • Organ Transplantation
  • Tissue Transplantation
    • By End User:
  • Hospital
  • Transplant Centers
  • Others
  • Europe
    • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
    • By Product Type:
  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs
    • By Application
  • Organ Transplantation
  • Tissue Transplantation
    • By End User:
  • Hospital
  • Transplant Centers
  • Others
  • Asia Pacific
    • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
    • By Product Type:
  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs
    • By Application
  • Organ Transplantation
  • Tissue Transplantation
    • By End User:
  • Hospital
  • Transplant Centers
  • Others
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
    • By Product Type:
  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs
    • By Application
  • Organ Transplantation
  • Tissue Transplantation
    • By End User:
  • Hospital
  • Transplant Centers
  • Others
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
    • By Product Type:
  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs
    • By Application
  • Organ Transplantation
  • Tissue Transplantation
    • By End User:
  • Hospital
  • Transplant Centers
  • Others
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
    • By Product Type:
  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs
    • By Application
  • Organ Transplantation
  • Tissue Transplantation
    • By End User:
  • Hospital
  • Transplant Centers
  • Others
  • Company Profiles
  • CryoLife, Inc.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Folio Biosciences
  • Arthrex
  • Abbvie, Inc.
  • Zimmer Biomet
  • Medtronic PLC
  • Novartis AG
  • Stryker Corporation
  • BiolifeSolutions, Inc.
  • Teva Pharmaceuticals
  • Veloxis Pharmaceutical

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Regulatory Scenario
  • Impact Analysis
  • PEST Analysis
  • Porter's Analysis
  • Advancements in Technological Innovations
  • Market Trends
  • Growth in Transplant Tourism
  • Key Developments

4. Global Tissue and Organ Transplantation Market - Impact of Coronavirus (Covid-19) Pandemic

  • Supply side Analysis
  • Demand Side Analysis
  • Impact on Healthcare Industry

5. Global Tissue and Organ Transplantation Market, By Product Type, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Tissue Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Preservation Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Immunosuppressive Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Tissue and Organ Transplantation Market, By Application, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Organ transplantation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Tissue transplantation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Tissue and Organ Transplantation Market, By End User, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Transplant Centers
    • Introduction
    • Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
    • Introduction
    • Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Tissue and Organ Transplantation Market, By Region, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2028
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East

9. Competitive Landscape

  • Company Profiles
    • CryoLife, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Folio Biosciences
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Arthrex
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Abbvie, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Zimmer Biomet
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Medtronic PLC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Stryker Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BiolifeSolutions, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Teva Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Veloxis Pharmaceutical
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact